Analysis of the Development Strategies of the Export of Chinese Active Pharmaceutical Ingredients

Abstract

Abstract: Objective To study the competitive advantages of Chinese active pharmaceutical ingredients by analyzing the international market situation and competition pattern of active pharmaceutical ingredient (API). Methods Through the analysis of the competition pattern of global API market, the advantages and shortcomings of China’s APIs in the international market were found out, and some development strategies and suggestions were put forward. Results and Conclusion It is urgent for China API enterprises to adjust their industrial structure, improve their production process, and actively participate in international certification for more export.

Key words:

API, export, development strategy

Zhou Yinhao, Dong Li.

Analysis of the Development Strategies of the Export of Chinese Active Pharmaceutical Ingredients

[J]. Asian Journal of Social Pharmacy, 2025, 20(4): 413-419.

Trendmd

[1]	Qiao Jiahui, Song Yu, Gong Jingran, Chen Yuwen. Research on the Threshold Effect of China’s Pharmaceutical Export Trade on Internal and External R&D Investment [J]. Asian Journal of Social Pharmacy, 2024, 19(2): 135-146.
[2]	Qiao Jiahui, Wang Su, Chen Yuwen. Research on the Relationship between Export Orientation and R&D Investment of China’s Pharmaceutical Industry in Different Regions [J]. Asian Journal of Social Pharmacy, 2021, 16(1): 48-59.
[3]	Kong Deqiang, Dong Li. Analysis of the Current Situation of Active Pharmaceutical Ingredient (API) Export in China [J]. Asian Journal of Social Pharmacy, 2019, 14(3): 126-134.
[4]	Xia Xing, Liu Yue, Dong Weitian, Zhao Xiaoyu, Liu Yunfan, Dong Li. Export of Health Care Products in China: Current Status and Countermeasures [J]. Asina Journal Of Social Pharmacy, 2018, 13(4): 142-147.
[5]	QIAN Yun-xu;ZHANG Zhong-peng;YANG Yue;BI Kai-shun. International Trade Status of Chinese Medicinal Materialsfrom 2000 to 2012 [J]. , 2014, 9(3): 115-118.
[6]	ZHANG Zhi-dong;SUN Li-hua. Chinese Herbal Medicine Exports: Existing Problems and Reflections [J]. , 2014, 9(2): 56-59.
[7]	GE Tian-tong;SUN Li-hua. Import and Export Situation of Chinese Traditional Patent Medicines [J]. , 2013, 8(4): 268-272.
[8]	WENG Xin-yu;CHEN Yu-wen;BI Kai-shun. A Study of the Directive 2011/62/EU [J]. , 2013, 8(4): 232-236.
[9]	LUO Lie;YANG Yue;HE Chun-hong. The Influence of EU Technical Barriers on the Export of Chinese Traditional Patent Medicine [J]. , 2012, 7(1): 22-27.
[10]	HUI Fei;ZHANG Fang. Analysis and Suggestion on China’s TCM Exports [J]. , 2011, 6(3): 145-150.
[11]	GAO Jing-mei;DONG Li;SUN Yuan-peng;LIU Juan;TANG Ya-jun. Patent Risk Analysis of China’s Pharmaceutical Export Enterprises [J]. , 2011, 6(3): 141-144.
[12]	GUO Ying;SONG Cheng-yun . Strategies for Active Pharmaceutical Ingredients (API) from China into US Market [J]. , 2010, 5(1): 23-27.
[13]	TANG Ya-jun;DONG Li;LIANG Jin-yu. A Study of TBT Chinese Medical Products Encounter [J]. , 2009, 4(4): 180-185.
[14]	GU Xuan;QIU Jia-xue. Strategies for the Traditional Chinese Medicine to Confront with the Green Barriers [J]. , 2008, 3(4): 193-196.
[15]	Yan Ming;Wang Dan. Study on strategies of improving the export competitive abilities of traditional Chinese medicinal materials [J]. , 2006, 1(1): 7-11.

Asian Journal Of Social Pharmacy

Analysis of the Development Strategies of the Export of Chinese Active Pharmaceutical Ingredients

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments